Effect of two amino acids in TM17 of sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators

Diabetes

Volumn 53, Issue SUPPL. 3, 2004, Pages

  Hambrock, Annette ^a   Kayar, Tülay ^a   Stumpp, Demet ^a   Osswald, Hartmut ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 1 (1,1 DIMETHYLPROPYL) 3 (3 PYRIDYL)GUANIDINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMINO ACID; APRIKALIM; DIAZOXIDE; GLIBENCLAMIDE; LEMAKALIM; PINACIDIL; POTASSIUM CHANNEL; RILMAKALIM; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR 1; UNCLASSIFIED DRUG;

ALLOSTERISM; AMINO ACID SEQUENCE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CHANNEL GATING; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; CELL LINE; CHROMANS; CROMAKALIM; DIAZOXIDE; GLYBURIDE; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTAGENESIS, SITE-DIRECTED; OOCYTES; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PYRROLIDINES; RATS; RECOMBINANT PROTEINS; TRANSFECTION; XENOPUS;

EID: 9444222643     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.suppl_3.S128     Document Type: Conference Paper

References (29)

1. Ashcroft SJH, Ashcroft FM: Properties and functions of ATP-sensitive K-channels. Cell Signal 2:197-214, 1990
2. ATP channels. Annu Rev Physiol 60:667-687, 1998
3. + channels. Prog Biophys Mol Biol 81:133-176, 2003
4. Lawson K: Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int 57:838-845, 2000
5. Coghlan MJ, Carroll WA, Gopalakrishnan M: Recent developments in the biology and medicinal chemistry of potassium channel modulators: Update from a decade of progress. J Med Chem 44:1627-1653, 2001
6. ATP channel openers: Structure-activity relationships and therapeutic potential. Med Res Rev 24:213-266, 2004
7. Schwanstecher M, Brandt C, Behrends S, Schaupp U, Panten U: Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic β-cell line and rat cerebral cortex. Br J Pharmacol 106:295-301, 1992
8. ATP channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. Mol Pharmacol 61:407-414, 2002
9. Uhde I, Toman A, Gross I, Schwanstecher C, Schwanstecher M: Identification of the potassium channel opener site on sulfonylurea receptors. J Biol Chem 274:28079-28082, 1999
10. Dabrowski M, Ashcroft FM, Ashfield R, Lebrun P, Pirotte B, Egebjerg J, Hansen JB, Wahl P: The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2, 4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes 51:1896-1906, 2002
11. Nielsen FE, Bodvarsdottir TB, Worsaae A, MacKay P, Stidsen CE, Boonen HCM, Pridal L, Arkhammar POG, Wahl P, Ynddal L, Junager F, Dragsted N, Tagmose TM, Mogensen JP, Koch A, Treppendahl SP, Hansen JB: 6-Chloro-3-alkylamino-4H- thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells. J Med Chem 45:4171-4187, 2002
12. + channel openers. Mol Pharmacol 56:308-315, 1999
13. ATP channel openers. Trends Pharmacol Sci 21:439-445, 2000
14. ATP channel openers. EMBO J 19: 6644-6651, 2000
15. Reimann F, Ashcroft FM, Gribble FM: Structural basis for the interference between nicorandil and sulfonylurea action. Diabetes 50:2253-2259, 2001
16. ATP channel. Diabetes 48:1341-1347, 1999
17. ATP channel. FEBS Lett 499:154-160, 2001
18. Ito K, Oleschuk CJ, Westlake C, Vasa MZ, Deeley RG, Cole SPC: Mutation of Trp(1254) in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J Biol Chem 276:38108-38114, 2001
19. ATP channel modulator binding to the recombinant sulphonylurea receptor, SUR2B. Br J Pharmacol 125:577-583, 1998
20. Hambrock A, Preisig-Müller R, Russ U, Piehl A, Hanley PJ, Ray J, Daut J, Quast U, Derst C: Four novel splice variants of sulfonylurea receptor 1. Am J Physiol Cell Physiol 238:587-598, 2002
21. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108, 1973
22. Draper NB, Smith H: Applied Regression Analysis. New York, Wiley, 1981, p. 22-33
23. Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J: Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J 17:5529-5535, 1998
24. Gribble FM, Tucker SJ, Ashcroft FM: The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO J 16:1145-1152, 1997
25. ATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol 110:643-654, 1997
26. + channel. J Biol Chem 271:24321-24324, 1996
27. + channel openers. J Biol Chem 275:717-720, 2000
28. Zhang DW, Cole SPC, Deeley RG: Identification of a nonconserved amino acid residue in multidrug resistance protein 1 important for determining substrate specificity: evidence for functional interaction between transmembrane helices 14 and 17. J Biol Chem 276:34966-34974, 2001
29. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JHM, Schinkel AH, Borst P: Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:23538-23544, 2003